In vivo imaging of immune rejection in transplanted pancreatic islets

Diabetes

Volumn 55, Issue 9, 2006, Pages 2419-2428

  Evgenov, Natalia V ^a   Medarova, Zdravka ^a   Pratt, John ^a   Pantazopoulos, Pamela ^a   Leyting, Simone ^a   Bonner Weir, Susan ^b   Moore, Anna ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

FDA, Food and Drug Administration; MRI, magnetic resonance imaging; TUNEL, transferase mediated dNTP nick end labeling

Indexed keywords

ENDOGENOUS COMPOUND; GAMMA INTERFERON; INTERLEUKIN 1BETA; SUPERPARAMAGNETIC IRON OXIDE; TUMOR NECROSIS FACTOR ALPHA; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL LABELING; CONTROLLED STUDY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GRAFT REJECTION; GRAFT SURVIVAL; HYPERGLYCEMIA; IMAGING; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CYTOCHEMISTRY; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS ISLET;

ANIMALS; CONTRAST MEDIA; DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; HISTOCYTOCHEMISTRY; HUMANS; IRON; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; OXIDES;

EID: 33750576754     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0484     Document Type: Article

References (39)

1. Shapiro A, Lakey J, Ryan E, Korbutt G, Toth E, Warnock G, Kneteman N, Rajotte R: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
2. Shapiro A, Ricordi C, Hering B: Edmonton's islet success has indeed been replicated elsewhere (Letter). Lancet 362:1242, 2003
3. Barshes N, Lee T, Goodpasture S, Brunicardi F, Alejandro R, Ricordi C, Soltes G, Barth M, Hamilton D, Goss J: Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a firstyear review. Transplant Proc 36:1127-1129, 2004
4. Ricordi C, Strom T: Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 4:259-268, 2004
5. Ryan E, Lakey J, Paty B, Imes S, Korbutt G, Kneteman N, Bigam D, Rajotte R, Shapiro A: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002
6. Ryan E, Paty B, Senior P, Bigam D, Alfadhli E, Kneteman N, Lakey J, Shapiro A: Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069, 2005
7. Gysemans C, Waer M, Valckx D, Laureys J, Mihkalsky D, Bouillon R, Mathieu C: Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-β mRNA in the grafts. Diabetes 49:1992-1997, 2000
8. Tan M, Di Carlo A, Liu S, Tector A, Tchervenkov J, Metrakos P: Hepatic sinusoidal endothelium upregulates IL-1alpha, IFN-gamma, and iNOS in response to discordant xenogeneic islets in an in vitro model of xenoislet transplantation. J Surg Res 102:229-236, 2002
9. Bottino R, Fernandez L, Ricordi C, Lehmann R, Tsan M, Oliver R, Inverardi L: Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47:316-323, 1998
10. Kaufman D, Gores P, Field M, Farney A, Gruber S, Stephanian E, Sutherland D: Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43:778-783, 1994
11. Bennet W, Sundberg B, Groth C, Brendel M, Brandhorst D, Brandhorst H, Bretzel R, Elgue G, Larsson R, Nilsson B, Korsgren O: Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48:1907-1914, 1999
12. Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A, Felldin M, Kallen R, Salmela K, Tibell A, Tufveson G, Ekdahl K, Elgue G, Korsgren O, Nilsson B: Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54:1755-1762, 2005
13. Shimabukuro M, Zhou Y, Levi M, Unger R: Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95:2498-2502, 1998
14. Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I, Unger R: Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A 97:8536-8541, 2000
15. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E: β-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66-72, 2002
16. Massoud T, Gambhir S: Molecular imaging in living subjects: seeing fundamental biological processes in a new light (Review). Genes Dev 17:545-580, 2003
17. Evgenov N, Medarova Z, Dai G, Bonner-Weir S, Moore A: In vivo imaging of islet transplantation. Nat Med 12:144-148, 2006
18. Ferrucci J, Stark D: Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years (Review). AJR Am J Roentgenol 155:943-950, 1990
19. Moore A, Weissleder R, Bodganov A: Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 7:1140-1145, 1997
20. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141-1147, 2001
21. Bulte J, Duncan I, Frank J: In vivo magnetic resonance tracking of magnetically labeled cells after transplantation (Review). J Cereb Blood Flow Metab 22:899-907, 2002
22. Arbab A, Yocum G, Kalish H, Jordan E, Anderson S, Khakoo A, Read E, Frank J: Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217-1223, 2004
23. Bulte J, Zhang S, van Gelderen P, Herynek V, Jordan E, Duncan I, Frank J: Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96:15256-15261, 1999
24. Josephson L, Tung C, Moore A, Weissleder R: High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186-191, 1999
25. Lewin M, Carlesso N, Tung C, Tang X, Cory D, Scadden D, Weissleder R: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18:410-414, 2000
26. Davalli A, Scaglia L, Zangen D, Hollister J, Bonner-Weir S, Weir G: Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function. Diabetes 45:1161-1167, 1996
27. Barshes N, Wyllie S, Goss J: Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts (Review). J Leukoc Biol 77:587-597, 2005
28. Prochazka M, Gaskins H, Shultz L, Leiter E: The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A 89:3290-3294, 1992
29. Kirchhof N, Shibata S, Wijkstrom M, Kulick DM, Salerno CT, Clemmings YH, Galili U, Sutherland DER, Dalmasso AP, Hering BJ: Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 11:396-407, 2004
30. Yasunami Y, Maki T, Nagai Y, Ikehara S, Kodama S, Ikeda S: Cellular immune response in the liver of mice rejecting intrahepatic rat and guinea pig islet xenografts: expansion of intermediate TCR cells. Transplant Proc 30:581, 1998
31. Li H, Ricordi C, Inverardi L: Effect of graft-versus-host reaction on intrahepatic islet transplants. Diabetes 48:2292-2299, 1999
32. Weissleder R, Stark D, Engelstad B, Bacon B, Compton C, White D, Jacobs P, Lewis J: Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152:167-173, 1989
33. Bodganov A, Martin C, Weissleder R, Brady T: Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. Biochim Biophys Acta 1193:212-218, 1994
34. Moore A, Marecos E, Bogdanov A, Weissleder R: Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568-574, 2000
35. Atkinson M, Maclaren N: What causes diabetes? (Review). Sci Am 263:62-67, 1990
36. Strom T: Saving islets from allograft rejection (Comment). Proc Natl Acad Sci U S A 102:12651-12652, 2005
37. Kriz J, Jirak D, Girman P, Berkova Z, Zacharovova K, Honsova E, Lodererova A, Hajek M, Saudek F: Magnetic resonance imaging of pancreatic islets in tolerance and rejection. Transplantation 80:1596-1603, 2005
38. Jirak D, Kriz J, Herynek V, Andersson B, Girman P, Burian M, Saudek F, Hajek M: MRI of transplanted pancreatic islets. Magn Reson Med 52:1228-1233, 2004
39. Arnush M, Heltmeler M, Scarlm A, Marino M, Manning P, Corbett J: IL-1 produced and released endogenously within human islets inhibits b-cell function. J Clin Invest 102:516-526, 1998